GB9015764D0
(en)
|
1990-07-18 |
1990-09-05 |
Fujisawa Pharmaceutical Co |
Pyrazolopyridine compound and processes for preparation thereof
|
KR970069028A
(ko)
|
1996-04-01 |
1997-11-07 |
김은영 |
화학색전용 에멀젼의 제조방법
|
EP0891334A1
(en)
|
1996-04-03 |
1999-01-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
WO1997036881A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
AU706497B2
(en)
|
1996-04-03 |
1999-06-17 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
EP0891343A1
(en)
|
1996-04-03 |
1999-01-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
WO1997036898A1
(en)
|
1996-04-03 |
1997-10-09 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
EP0891356A1
(en)
|
1996-04-03 |
1999-01-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
GB9609441D0
(en)
|
1996-05-04 |
1996-07-10 |
Zeneca Ltd |
Process
|
JP2000514061A
(ja)
|
1996-06-28 |
2000-10-24 |
メルク エンド カンパニー インコーポレーテッド |
フィブリノーゲン受容体拮抗物質
|
US5755056A
(en)
|
1996-07-15 |
1998-05-26 |
Remington Arms Company, Inc. |
Electronic firearm and process for controlling an electronic firearm
|
US5877193A
(en)
*
|
1996-07-19 |
1999-03-02 |
Hoffmann-La Roche Inc. |
Use of N-(4-aryl-thiazol-2-yl)-sulfonamides
|
DZ2376A1
(fr)
|
1996-12-19 |
2002-12-28 |
Smithkline Beecham Plc |
Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
|
AU744475B2
(en)
|
1997-04-24 |
2002-02-28 |
Bristol-Myers Squibb Company |
Methods and compositions for use in modulating expression of matrix metalloproteinase genes
|
ES2231757T3
(es)
|
1997-09-05 |
2005-05-16 |
Glaxo Group Limited |
Composiciones farmaceutica que comprenden derivados de 2,3-diaril-pirazolo (1,5-b) piridazina.
|
DE69943247D1
(de)
*
|
1998-03-27 |
2011-04-14 |
Janssen Pharmaceutica Nv |
HIV hemmende Pyrimidin Derivate
|
US6294558B1
(en)
*
|
1999-05-31 |
2001-09-25 |
Pfizer Inc. |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
|
GB9812768D0
(en)
|
1998-06-13 |
1998-08-12 |
Zeneca Ltd |
Methods
|
BR9914666A
(pt)
|
1998-10-22 |
2001-07-17 |
Hoffmann La Roche |
Derivados de tiazol
|
DE69919887T2
(de)
|
1998-11-03 |
2005-09-15 |
Glaxo Group Ltd., Greenford |
Pyrazolopyridin derivative als selektive cox-2 inhibitoren
|
ES2252996T3
(es)
*
|
1999-01-13 |
2006-05-16 |
Warner-Lambert Company Llc |
Derivados de bencenosulfonamida y su uso como inhibidores de mek.
|
FR2788770B1
(fr)
|
1999-01-21 |
2001-02-16 |
Oreal |
Nouveaux 2-sulfonylaminophenols cationiques, leur utilisation a titre de coupleur pour la teinture d'oxydation, compositions les comprenant et procedes de teinture
|
EP1157025B1
(en)
|
1999-02-27 |
2004-03-10 |
Glaxo Group Limited |
Pyrazolopyridines
|
GB9904930D0
(en)
*
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Thiazoloindolinone compounds
|
EP1173254A2
(en)
|
1999-04-27 |
2002-01-23 |
Smithkline Beecham Plc |
Novel treatment of neurotraumatic conditions with a raf inhibitor
|
UA71971C2
(en)
*
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
WO2001005768A1
(fr)
|
1999-07-19 |
2001-01-25 |
Shionogi & Co., Ltd. |
Composes tricycliques porteurs de pendants acyloxymethoxycarbonyle
|
CA2375982A1
(en)
|
1999-07-23 |
2001-02-01 |
Shionogi & Co., Ltd. |
Th2 differentiation inhibitors
|
AU6016000A
(en)
|
1999-07-23 |
2001-02-13 |
Shionogi & Co., Ltd. |
Tricyclic compounds and drug compositions containing the same
|
RU2002110295A
(ru)
|
1999-09-17 |
2003-12-10 |
Милленниум Фармасьютикалс, Инк. (Us) |
Ингибиторы фактора Ха
|
CZ2002961A3
(cs)
|
1999-09-17 |
2002-08-14 |
Millennium Pharmaceuticals, Inc. |
Benzamidy a příbuzné sloučeniny pro inhibici faktoru Xa
|
US6632815B2
(en)
|
1999-09-17 |
2003-10-14 |
Millennium Pharmaceuticals, Inc. |
Inhibitors of factor Xa
|
ATE311385T1
(de)
|
1999-10-27 |
2005-12-15 |
Novartis Pharma Gmbh |
Thiazol und imidazo(4,5-b)pyridin verbindungen und ihre verwendung als pharmazeutika
|
DE60037597T2
(de)
|
1999-11-22 |
2008-12-11 |
Smithkline Beecham P.L.C., Brentford |
Imidazol- Derivate
|
AU2001234689A1
(en)
|
2000-02-01 |
2001-08-14 |
Cor Therapeutics, Inc. |
Bivalent phenylene inhibitors of factor xa
|
ATE311366T1
(de)
|
2000-02-29 |
2005-12-15 |
Millennium Pharm Inc |
Benzamide und ähnliche inhibitoren vom faktor xa
|
WO2001072745A1
(en)
|
2000-03-29 |
2001-10-04 |
Cyclacel Limited |
2-substituted 4-heteroaryl-pyrimidines and their use in the treatmetn of proliferative disorders
|
JP3831253B2
(ja)
|
2000-04-04 |
2006-10-11 |
塩野義製薬株式会社 |
高脂溶性化合物を含有する油性組成物
|
WO2001076582A1
(fr)
|
2000-04-05 |
2001-10-18 |
Shionogi & Co., Ltd. |
Micro-emulsions huile dans eau contenant des composes tricycliques ou des preconcentres de ceux-ci
|
WO2001077091A2
(en)
|
2000-04-05 |
2001-10-18 |
Tularik Inc. |
Ns5b hcv polymerase inhibitors
|
EP1276742B1
(en)
|
2000-04-28 |
2004-06-09 |
Glaxo Group Limited |
Process for the preparation of pyrazolopyridine derivatives
|
AU2001256765A1
(en)
|
2000-05-16 |
2001-11-26 |
Nippon Soda Co., Ltd. |
Phenyloxazole compounds and fungicides for agricultural and horticultural use
|
ATE272617T1
(de)
|
2000-06-13 |
2004-08-15 |
Lilly Co Eli |
Sulfonamid-derivate
|
WO2002000647A1
(en)
|
2000-06-23 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Heteroaryl-phenyl substituted factor xa inhibitors
|
PE20020506A1
(es)
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
Derivados de pirazol fusionados como inhibidores de la proteina cinasa
|
US20040067938A1
(en)
|
2000-09-29 |
2004-04-08 |
Penglie Zhang |
Quaternary amines and related inhibitors of factor xa
|
US6919352B2
(en)
|
2000-12-15 |
2005-07-19 |
Smithkline Beecham Corporation |
Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds
|
DE60112330T2
(de)
|
2000-12-15 |
2006-04-13 |
Glaxo Group Ltd., Greenford |
Pyrazolopyridinderivate
|
WO2002053101A2
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
EP1364949A4
(en)
|
2001-02-02 |
2005-11-23 |
Takeda Pharmaceutical |
INHIBITOR OF JNK
|
WO2002070469A2
(en)
|
2001-03-05 |
2002-09-12 |
Icos Corporation |
Selective pde3b inhibitors and use of the same in therapy
|
ATE274515T1
(de)
|
2001-03-08 |
2004-09-15 |
Smithkline Beecham Corp |
Pyrazolopyridinderivate
|
WO2002078701A1
(en)
|
2001-03-30 |
2002-10-10 |
Smithkline Beecham Corporation |
Use of pyrazolopyridines as therapeutic compounds
|
EP1372643A1
(en)
|
2001-03-30 |
2004-01-02 |
Smithkline Beecham Corporation |
Pyrazolopyridines, process for their preparation and use as therapeutic compounds
|
DE60212949T2
(de)
|
2001-04-10 |
2007-01-04 |
Smithkline Beecham Corp. |
Antivirale pyrazolopyridin verbindungen
|
NZ529043A
(en)
|
2001-04-16 |
2006-11-30 |
Tanabe Seiyaku Co |
Large conductance calcium-activated K channel opener
|
ATE296826T1
(de)
|
2001-04-27 |
2005-06-15 |
Smithkline Beecham Corp |
Pyrazolo(1,5)pyridinderivate
|
BR0210191A
(pt)
|
2001-06-06 |
2004-04-06 |
Agouron Pharma |
Agentes não peptìdicos da gnrh, composições farmacêuticas e métodos para o seu uso, e processos para os preparar e aos seus intermediários
|
PL366827A1
(en)
|
2001-06-21 |
2005-02-07 |
Smithkline Beecham Corporation |
Imidazo[1,2-a]pyridine derivatives for the prophylaxis and treatment of herpes viral infections
|
AUPR738301A0
(en)
|
2001-08-30 |
2001-09-20 |
Starpharma Limited |
Chemotherapeutic agents
|
US7446106B2
(en)
|
2001-09-05 |
2008-11-04 |
Smithkline Beecham Plc |
Pyridylfurans and pyrroles as Raf kinase inhibitors
|
EP1423389B1
(en)
|
2001-09-07 |
2007-06-06 |
SmithKline Beecham Corporation |
Pyrazolo-pyridines for the treatment of herpes infections
|
GB0123589D0
(en)
|
2001-10-01 |
2001-11-21 |
Syngenta Participations Ag |
Organic compounds
|
WO2003031446A1
(en)
|
2001-10-05 |
2003-04-17 |
Smithkline Beecham Corporation |
Imidazo-pyridine derivatives for use in the treatment of herpes viral infection
|
DE10154125A1
(de)
|
2001-10-25 |
2003-05-22 |
Zeiss Carl Semiconductor Mfg |
Messverfahren und Messsystem zur Vermessung der Abbildungsqualität eines optischen Abbildunsgssystems
|
CA2466762A1
(en)
*
|
2001-12-04 |
2003-06-12 |
Onyx Pharmaceuticals, Inc. |
Raf-mek-erk pathway inhibitors to treat cancer
|
WO2003050120A1
(en)
|
2001-12-11 |
2003-06-19 |
Smithkline Beecham Corporation |
Pyrazolo-pyridine derivatives as antiherpes agents
|
EP1509614A4
(en)
|
2002-02-15 |
2007-09-12 |
Gen Hospital Corp |
MAP KINASE INHIBITORS FOR REGULATING TUMOR ASSOCIATED ANTIGENE EXPRESSION
|
JP2005525382A
(ja)
|
2002-03-07 |
2005-08-25 |
スミスクライン ビーチャム コーポレーション |
ピラゾロピリミジンおよびピラゾロトリアジン誘導体ならびにそれを含む医薬組成物
|
GB0205693D0
(en)
|
2002-03-09 |
2002-04-24 |
Astrazeneca Ab |
Chemical compounds
|
AR039241A1
(es)
|
2002-04-04 |
2005-02-16 |
Biogen Inc |
Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
|
WO2003090751A1
(en)
|
2002-04-26 |
2003-11-06 |
Pfizer Products Inc. |
Pyrimidine-2, 4, 6-trione metallo-proteinase inhibitors
|
NI200300045A
(es)
|
2002-04-26 |
2005-07-08 |
Pfizer Prod Inc |
Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa.
|
JP2005529919A
(ja)
|
2002-05-10 |
2005-10-06 |
スミスクライン ビーチャム コーポレーション |
治療用化合物
|
WO2004000318A2
(en)
|
2002-06-21 |
2003-12-31 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
KR20050071471A
(ko)
|
2002-08-08 |
2005-07-07 |
스미스클라인 비참 코포레이션 |
티오펜 화합물
|
CA2497597A1
(en)
|
2002-09-11 |
2004-03-11 |
Sequenom, Inc. |
Methods for identifying subjects at risk of melanoma and treatments
|
WO2004028352A2
(en)
|
2002-09-30 |
2004-04-08 |
Bayer Pharmaceuticals Corporation |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
US20040157836A1
(en)
*
|
2002-10-08 |
2004-08-12 |
Comess Kenneth M. |
Sulfonamides having antiangiogenic and anticancer activity
|
WO2004043368A2
(en)
|
2002-11-06 |
2004-05-27 |
Smithkline Beecham Corporation |
Sulfonamides
|
SE0203754D0
(sv)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
US7125997B2
(en)
|
2002-12-20 |
2006-10-24 |
Irm Llc |
Differential tumor cytotoxicity compounds and compositions
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
US6893159B1
(en)
|
2003-01-27 |
2005-05-17 |
Christopher Eugene Hosmer |
Lubrication free connection
|
JP2006519258A
(ja)
|
2003-02-28 |
2006-08-24 |
エンサイシブ・ファーマシューティカルズ・インコーポレイテッド |
ピリジン、ピリミジン、キノリン、キナゾリンおよびナフタレン系のウロテンシン−ii受容体拮抗薬
|
EP1611123B8
(en)
|
2003-04-09 |
2013-11-13 |
Exelixis, Inc. |
Tie-2 modulators and methods of use
|
WO2004092146A2
(en)
|
2003-04-14 |
2004-10-28 |
The Institutes For Pharmaceutical Discovery, Llc |
N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
|
US20070099250A1
(en)
|
2003-04-14 |
2007-05-03 |
Ping Hu |
Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases
|
WO2004099168A2
(en)
|
2003-04-30 |
2004-11-18 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted carboxylic acids
|
AU2004236247B2
(en)
|
2003-04-30 |
2008-11-06 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1 B
|
MXPA05011536A
(es)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Acidos carboxilicos substituidos con fenilo como inhibidores de la proteina tirosina fosfatasa-1b.
|
MXPA05011539A
(es)
|
2003-04-30 |
2006-01-23 |
Inst For Pharm Discovery Inc |
Acidos carboxilicos sustituidos con heterociclo como inhibidores de la proteina tirosina-fosfatasa-1b.
|
SE0301650D0
(sv)
|
2003-06-04 |
2003-06-04 |
Astrazeneca Ab |
Novel compounds
|
CA2528003A1
(en)
|
2003-06-10 |
2004-12-23 |
Kalypsys, Inc. |
Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
|
GB0315111D0
(en)
|
2003-06-27 |
2003-07-30 |
Cancer Rec Tech Ltd |
Substituted 5-membered ring compounds and their use
|
GB0315517D0
(en)
|
2003-07-02 |
2003-08-06 |
Barrett Kevin J |
Earth clamp
|
WO2005007090A2
(en)
|
2003-07-03 |
2005-01-27 |
President And Fellows Of Harvard College |
Inhibitors of the map kinase pathway
|
JP2007500178A
(ja)
|
2003-07-30 |
2007-01-11 |
サイクラセル・リミテッド |
プロテインキナーゼ阻害剤としてのピリジニルアミノ−ピリミジン誘導体
|
WO2005047542A1
(en)
|
2003-10-16 |
2005-05-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Treatments for inhibiting development and progression of nevi and melanoma having braf mutations
|
WO2005042525A1
(en)
|
2003-10-21 |
2005-05-12 |
Cyclacel Limited |
Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
|
GB0325956D0
(en)
|
2003-11-06 |
2003-12-10 |
Addex Pharmaceuticals Sa |
Novel compounds
|
EP1709007A1
(en)
|
2004-01-22 |
2006-10-11 |
Altana Pharma AG |
N-4-(6-(heteo)aryl-pyrimidin-4-ylaminophenyl)-benzenesulfonamides as kinase inhibitors
|
CN1934107A
(zh)
|
2004-01-30 |
2007-03-21 |
Ab科学公司 |
作为酪氨酸激酶抑制剂的2-(3-取代芳基)氨基-4-芳基-噻唑
|
US20090253908A1
(en)
|
2004-03-11 |
2009-10-08 |
Glaxo Group Limited |
Novel m3 muscarinic acetylchoine receptor antagonists
|
WO2005086873A2
(en)
|
2004-03-11 |
2005-09-22 |
Glaxo Group Limited |
Novel m3 muscarinic acetylcholine receptor antagonists
|
WO2005090296A2
(en)
|
2004-03-11 |
2005-09-29 |
Elan Pharmaceuticals, Inc. |
N-substituted benzene sulfonamides
|
JP2007530453A
(ja)
|
2004-03-19 |
2007-11-01 |
ザ ペン ステート リサーチ ファウンデーション |
黒色腫を治療するためのコンビナトリアル法および組成物
|
DE102004018198A1
(de)
|
2004-04-15 |
2005-11-03 |
Merck Patent Gmbh |
Sulfonamide
|
US20050267032A1
(en)
|
2004-05-21 |
2005-12-01 |
Icagen, Inc. |
Sulfone-containing prodrugs
|
GB0411791D0
(en)
|
2004-05-26 |
2004-06-30 |
Cyclacel Ltd |
Compounds
|
PL1761528T3
(pl)
|
2004-06-11 |
2008-05-30 |
Japan Tobacco Inc |
Pochodne 5-amino-2,4,7-triokso-3,4,7,8-tetrahydro-2H-pirydo[2,3-D]pirymidyny i związki pokrewne do leczenia raka
|
JP2007223903A
(ja)
|
2004-07-09 |
2007-09-06 |
Takeda Chem Ind Ltd |
新規な固体分散体およびその製造方法
|
KR20070041762A
(ko)
*
|
2004-07-28 |
2007-04-19 |
글락소 그룹 리미티드 |
위장관 장애의 치료에 유용한 피페라진 유도체
|
KR20070049655A
(ko)
|
2004-08-13 |
2007-05-11 |
제넨테크, 인크. |
Atp-이용 효소 억제 활성을 나타내는2-아미도-티아졸-기재 화합물과 조성물 및 이들의 용도
|
AU2005280167A1
(en)
|
2004-08-31 |
2006-03-09 |
Biogen Idec Ma Inc. |
Pyrimidinylpyrazoles as TGF-beta inhibitors
|
GB0420424D0
(en)
|
2004-09-14 |
2004-10-20 |
Ionix Pharmaceuticals Ltd |
Therapeutic compounds
|
JP4810814B2
(ja)
|
2004-09-15 |
2011-11-09 |
オムロン株式会社 |
光学シート及び面光源装置
|
EP1640018A1
(en)
|
2004-09-24 |
2006-03-29 |
Universität Zürich |
Combinational therapy for treating cancer
|
JP2008514608A
(ja)
|
2004-09-24 |
2008-05-08 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルホンアミド化合物
|
EP1804801A2
(en)
|
2004-10-15 |
2007-07-11 |
Biogen Idec MA, Inc. |
Methods of treating vascular injuries
|
EP1805157A2
(en)
|
2004-10-26 |
2007-07-11 |
Third-Order Nanotechnologies, Inc. |
Tricyclic spacer systems for nonlinear optical devices
|
AU2005302475A1
(en)
|
2004-10-28 |
2006-05-11 |
The Institutes For Pharmaceutical Discovery, Llc |
Substituted phenylalkanoic acids
|
TW200631949A
(en)
|
2004-10-28 |
2006-09-16 |
Inst For Pharm Discovery Inc |
Substituted carboxylic acids
|
US20060134068A1
(en)
|
2004-11-09 |
2006-06-22 |
Mount Sinai School Of Medicine Of New York University |
Treatment of cancer by simultaneous inhibiton of BRAF and restoration or mimicry of p16INK4A activity
|
US7713998B2
(en)
|
2004-11-10 |
2010-05-11 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic compound and pharmaceutical use thereof
|
EP1957075A4
(en)
|
2004-11-15 |
2009-11-18 |
Glaxo Group Ltd |
NOVEL ANTAGONISTS OF ACETYLCHOLINE M3 TYPE MUSCARINIC RECEPTORS
|
EP1827439A4
(en)
|
2004-11-15 |
2009-11-18 |
Glaxo Group Ltd |
NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
|
EP1814869A2
(en)
|
2004-11-18 |
2007-08-08 |
The Institutes for Pharmaceutical Discovery, LLC |
Substituted amino acids as protein tyrosine phosphatase inhibitors
|
EP1836182A2
(en)
|
2004-11-18 |
2007-09-26 |
The Institutes for Pharmaceutical Discovery, LLC |
Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
|
CA2588766A1
(en)
|
2004-11-18 |
2006-05-26 |
The Institutes For Pharmaceutical Discovery, Llc |
Heterocycle substituted carboxylic acids
|
WO2006064375A2
(en)
|
2004-12-16 |
2006-06-22 |
Ab Science |
Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases
|
WO2006068826A2
(en)
|
2004-12-21 |
2006-06-29 |
Smithkline Beecham Corporation |
2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
|
US7812022B2
(en)
|
2004-12-21 |
2010-10-12 |
Glaxosmithkline Llc |
2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
AU2006204750C1
(en)
|
2005-01-14 |
2012-11-01 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
WO2006113261A2
(en)
*
|
2005-04-14 |
2006-10-26 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
US7880008B2
(en)
|
2005-05-31 |
2011-02-01 |
Vertex Pharmaceuticals Incorporated |
Heterocycles useful as modulators of ion channels
|
MY153898A
(en)
|
2005-06-22 |
2015-04-15 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
WO2007003036A1
(en)
|
2005-06-30 |
2007-01-11 |
Streetlight Intelligence, Inc. |
Method and system for luminance characterization
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
WO2007009013A2
(en)
|
2005-07-13 |
2007-01-18 |
University Of Utah Research Foundation |
Methods and compositions related to a braf mutation and microsatellite stability
|
US7713960B2
(en)
|
2005-07-22 |
2010-05-11 |
University Of South Florida |
Inhibition of the Raf/Mek/P-Erk pathway for treating cancer
|
BRPI0616574A2
(pt)
|
2005-09-27 |
2009-11-24 |
Shionogi & Co |
derivado de sulfonamida tendo atividade antagonìstica de receptor de pgd2
|
US7910742B2
(en)
|
2005-09-29 |
2011-03-22 |
Abbott Laboratories |
Survivin inhibitors
|
EP1932840B1
(en)
|
2005-10-03 |
2014-04-09 |
Ono Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
|
PT1951692E
(pt)
|
2005-11-07 |
2010-10-28 |
Irm Llc |
Moduladores de ppar contendo oxazole e tiazole
|
RU2008122548A
(ru)
|
2005-11-07 |
2009-12-20 |
Айрм Ллк (Bm) |
Соединения и композиции, как модуляторы арпп (активированных рецепторов пролифератора пероксисом)
|
TW200736260A
(en)
|
2005-11-10 |
2007-10-01 |
Smithkline Beecham Corp |
Inhibitors of Akt activity
|
EP1951716B1
(en)
|
2005-11-16 |
2011-05-04 |
Vertex Pharmaceuticals, Inc. |
Aminopyrimidines useful as kinase inhibitors
|
US7625896B2
(en)
|
2005-11-25 |
2009-12-01 |
Hoffman-La Roche Inc. |
Pyridylsulfonamide derivatives
|
CN101326182B
(zh)
|
2005-12-05 |
2011-09-28 |
史密丝克莱恩比彻姆公司 |
2-嘧啶基吡唑并吡啶ErbB激酶抑制剂
|
US20070135368A1
(en)
|
2005-12-09 |
2007-06-14 |
Knapp Pamela E |
Cell-to-cell transmission of siRNA induced gene silencing in mammalian cells
|
CA2633653A1
(en)
|
2005-12-21 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic derivatives as modulators of ion channels
|
EA200801716A1
(ru)
*
|
2006-01-18 |
2009-04-28 |
Амген Инк. |
Тиазольные соединения и их применение
|
US7560551B2
(en)
*
|
2006-01-23 |
2009-07-14 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
NZ569815A
(en)
|
2006-01-23 |
2011-11-25 |
Amgen Inc |
Aurora kinase modulators and method of use
|
US20070275960A1
(en)
|
2006-01-25 |
2007-11-29 |
Synta Pharmaceuticals Corp. |
Phenyl and pyridyl compounds for inflammation and immune-related uses
|
US20070219239A1
(en)
|
2006-02-10 |
2007-09-20 |
Mjalli Adnan M |
Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
|
WO2007113202A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Glaxo Group Limited |
Piperazine derivatives as growth hormone secretagogue (ghs) receptor agonists
|
US7351434B2
(en)
|
2006-04-07 |
2008-04-01 |
Academia Sinica |
Therapeutic Gastrodia extracts
|
JP2010523466A
(ja)
*
|
2006-04-13 |
2010-07-15 |
グラクソ グループ リミテッド |
成長ホルモン分泌促進因子受容体アゴニストとしてのアリールおよびヘテロアリールスルホンアミド類
|
JP2009534380A
(ja)
|
2006-04-20 |
2009-09-24 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
c−fmsキナーゼインヒビター
|
WO2007131953A1
(en)
|
2006-05-12 |
2007-11-22 |
Ab Science |
A new process for the synthesis of 2-aminoxazole compounds
|
EP2037905B1
(en)
|
2006-06-23 |
2013-05-01 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
EP2041114B1
(en)
|
2006-07-07 |
2016-03-02 |
NephroGenex, Inc. |
Inhibitors of advanced glycation end products
|
CA2654898A1
(en)
|
2006-07-07 |
2008-10-01 |
Boehringer Ingelheim International Gmbh |
New chemical compounds
|
WO2008013928A2
(en)
|
2006-07-28 |
2008-01-31 |
Biogen Idec Ma Inc. |
Treatment of cancer with interferon gene delivery in combination with a tgf-beta inhibitor
|
DK2054397T3
(en)
|
2006-08-16 |
2016-01-18 |
J David Gladstone Inst A Testamentary Trust Established Under The Will Of J David Gladstone |
SMALL MOLECULAR INHIBITORS OF KYNURENIN-3-MONOOXYGENASE
|
WO2008022286A2
(en)
|
2006-08-16 |
2008-02-21 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Small molecule inhibitors of kynurenine-3-monooxygenase
|
GB0622202D0
(en)
|
2006-11-07 |
2006-12-20 |
Addex Pharmaceuticals Sa |
Novel compounds
|
SG10201504425SA
(en)
|
2006-12-08 |
2015-07-30 |
Millennium Pharm Inc |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
EP2125808A2
(en)
|
2006-12-15 |
2009-12-02 |
Bayer Schering Pharma Aktiengesellschaft |
3-h-pyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
US8207196B2
(en)
|
2007-02-02 |
2012-06-26 |
Baylor College Of Medicine |
Compositions and methods for the treatment of metabolic disorders
|
CA2713303A1
(en)
|
2007-02-26 |
2008-09-04 |
John Wayne Cancer Institute |
Utility of b-raf dna mutation in diagnosis and treatment of cancer
|
WO2008104077A1
(en)
|
2007-02-28 |
2008-09-04 |
Methylgene Inc. |
Small molecule inhibitors of protein arginine methyltransferases (prmts)
|
CN101668737A
(zh)
*
|
2007-03-08 |
2010-03-10 |
普莱希科公司 |
Ppar活性化合物
|
WO2008120004A1
(en)
|
2007-04-02 |
2008-10-09 |
Astrazeneca Ab |
Combination of a mek- inhibitor and a b-raf inhibitor for the treatment of cancer
|
WO2008129288A2
(en)
|
2007-04-19 |
2008-10-30 |
Boehringer Ingelheim International Gmbh |
Disulfonamides useful in the treatment of inflammation
|
CL2008001356A1
(es)
*
|
2007-05-10 |
2008-11-14 |
Smithkline Beecham Corp |
Compuestos derivados de quinoxalina, inhibidores de la pi3 quinasa _(p13ka, pi3ko, pi3b y/o pi3ky); composicion farmaceutica; uso para tratar un trastorno autoinmune, enfermedad inflamatoria, cardiovascular, neurodegerativa, alergia, asma, enfermedad renal, cancer, rechazo de transplante, lesiones pulmonares.
|
EP2162552A4
(en)
|
2007-05-11 |
2010-06-30 |
Univ Johns Hopkins |
BIOMARKERS FOR MELANOMES
|
EP2162454B1
(en)
*
|
2007-06-01 |
2013-01-02 |
GlaxoSmithKline LLC |
Imidazopyridine kinase inhibitors
|
EP2170814B1
(en)
|
2007-06-12 |
2016-08-17 |
Achaogen, Inc. |
Antibacterial agents
|
US20100240657A1
(en)
|
2007-07-02 |
2010-09-23 |
Boehringer Ingelheim International Gmbh |
Chemical compounds
|
WO2009010871A2
(en)
|
2007-07-13 |
2009-01-22 |
Addex Pharma S.A. |
Pyrazole derivatives as antagonists of adenosine a3 receptor
|
WO2009011850A2
(en)
|
2007-07-16 |
2009-01-22 |
Abbott Laboratories |
Novel therapeutic compounds
|
CN101808994B
(zh)
|
2007-07-17 |
2013-05-15 |
普莱希科公司 |
用于激酶调节的化合物和方法以及其适应症
|
CA2699290C
(en)
|
2007-09-11 |
2018-05-15 |
University Of Massachusetts |
Insulin-like growth factor binding protein 7 for treatment of cancer
|
CL2008002793A1
(es)
|
2007-09-20 |
2009-09-04 |
Cgi Pharmaceuticals Inc |
Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
|
WO2009062122A1
(en)
|
2007-11-09 |
2009-05-14 |
John Wayne Cancer Institute |
Utility of ret mutant in diagnosis and treatment of melanoma
|
GB0722680D0
(en)
|
2007-11-19 |
2007-12-27 |
Topotarget As |
Therapeutic compounds and their use
|
US20110098296A1
(en)
|
2007-12-13 |
2011-04-28 |
George Adjabeng |
Thiazole And Oxazole Kinase Inhibitors
|
WO2009106708A2
(fr)
|
2007-12-18 |
2009-09-03 |
Sanofi-Aventis |
Derives d'azetidines, leur preparation et leur application en therapeutique
|
JPWO2009096198A1
(ja)
|
2008-02-01 |
2011-05-26 |
一般社団法人ファルマIp |
新規ビアリール誘導体
|
WO2009098576A1
(en)
*
|
2008-02-05 |
2009-08-13 |
Pfizer Inc. |
Pyridinyl amides for the treatment of cns and metabolic disorders
|
WO2009100214A2
(en)
|
2008-02-05 |
2009-08-13 |
The Johns Hopkins University |
Induction of thyroid iodide-handling gene expression in human cancers
|
US20090275546A1
(en)
|
2008-04-10 |
2009-11-05 |
Istituto Superiore Di Sanita |
Diagnostic tests and personalized treatment regimes for cancer stem cells
|
US8198284B2
(en)
|
2008-04-30 |
2012-06-12 |
National Health Research Institutes |
Treatment of neurodegenerative disorders with thiourea compounds
|
UA103319C2
(en)
*
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
US8133884B2
(en)
|
2008-05-06 |
2012-03-13 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
JP2011527345A
(ja)
|
2008-07-07 |
2011-10-27 |
ファスジェン, インコーポレイテッド |
新規な化合物、この化合物を含む医薬組成物、この化合物の使用方法、およびこの化合物の調製方法
|
ES2386408T3
(es)
|
2008-07-24 |
2012-08-20 |
Nerviano Medical Sciences S.R.L. |
3,4-Diarilpirazoles como inhibidores de proteína quinasa
|
NZ601483A
(en)
|
2008-08-04 |
2013-10-25 |
Chdi Foundation Inc |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
WO2010018458A2
(en)
|
2008-08-12 |
2010-02-18 |
Crystalgenomics, Inc. |
Phenol derivatives and methods of use thereof
|
CA2734428A1
(en)
|
2008-08-18 |
2010-02-25 |
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. |
Susceptibility to hsp90-inhibitors
|
GB0815947D0
(en)
|
2008-09-02 |
2008-10-08 |
Univ Dundee |
Compounds
|
US8499305B2
(en)
|
2010-10-15 |
2013-07-30 |
Via Technologies, Inc. |
Systems and methods for performing multi-program general purpose shader kickoff
|